Ventral Hernias Clinical Trial
Official title:
Multicentric Evaluation of the Proceed Ventral Patch for Umbilical and Small Primary Ventral Hernias Less Than 3cm Diameter With One Year Follow-up
Verified date | December 2014 |
Source | University Hospital, Ghent |
Contact | n/a |
Is FDA regulated | No |
Health authority | Belgium: Ethics Committee |
Study type | Interventional |
For small (2-3cm) ventral and umbilical hernias the discussion for primary suture repair or
the use of mesh continues.
About 5 years ago the Ventralex patch was introduced, which combines a layer of PTFE mesh
with a small polypropylene mesh and includes a circular memory ring. Despite the elegance of
using this patch, recent experience showed several drawbacks both in design and efficacy
(3).
With the recent development of the Proceed Ventral Patch (PVP), new elements have been
introduced to overcome some of these issues.
The aim of this study is to evaluate the efficacy of clinical placement of the PVP in the
intra-abdominal position in the treatment of small ventral hernias.
Status | Completed |
Enrollment | 160 |
Est. completion date | September 2013 |
Est. primary completion date | April 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Adult patient - Written informed consent - Umbilical, primary ventral hernias smaller than 3cm diameter Exclusion Criteria: - Hernias larger than 3cm - Recurrence - Children - Emergency cases - Incisional hernias |
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Belgium | Imelda Hospital | Bonheiden | |
Belgium | University Hospital Ghent | Ghent |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Ghent | Johnson & Johnson |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percentage of adequately placed patches | At T 0 days | No | |
Secondary | Perioperative morbidity rate | Within 30 days | No | |
Secondary | Pre- and postoperative pain | At T 0 day, T 30 days and T 1 year | No | |
Secondary | Number of patients needed a repositioning of the patch | At T 0 days | No | |
Secondary | Reasons for inadequate positioning | At T 0 days | No | |
Secondary | Number of repositioning necessary | At T 0 days | No | |
Secondary | Complication ratio | At 1 year | No | |
Secondary | Recurrence rate at 1 year | At 1 year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01673568 -
Abdominal Binder to Reduce Pain and Seroma Formation
|
N/A | |
Completed |
NCT01962480 -
The Effect of Laparoscopically Closing the Hernia Defect in Laparoscopic Ventral Hernia Repair on Postoperative Pain
|
N/A | |
Withdrawn |
NCT02730936 -
Antimicrobial Hernia Repair Device
|
N/A | |
Completed |
NCT01784822 -
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
|
N/A |